API RED LIST Who's out. Who's in.
WARNING LETTER · 29 OCT 2026IA 66-79FEI 3040333997 · Changshou, Chongqing

Chongqing Qiancan: de-registered the week FDA asked for records

An API maker shipping to US compounders got a records request in June, dropped its FDA registration twelve days later, then signed back up. FDA blocked its drugs at the border in August.

What FDA found
  1. Import records showed several API shipments for US prescription compounding that named Qiancan as the maker.
  2. FDA asked for records on 17 June 2026. Qiancan de-registered and pulled its drug listing on 29 June, then replied that it could not meet FDA requirements.
  3. No records were ever sent, though its API was still in the US market and within expiry.
  4. The firm registered with FDA again on 13 July 2026.
Timeline

How it got here

17 JUN 2026 FDA records request under section 704(a)(4)
29 JUN 2026 Qiancan de-registers and drops its drug listing
30 JUN 2026 Replies it cannot meet FDA requirements
13 JUL 2026 Registers again
26 AUG 2026 All drugs placed on Import Alert 66-79
29 OCT 2026 Warning Letter

They're out. Someone else makes it.

Open the list on API-FDF

Sources